Michele Mercuri

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.

R. Nitsch, C. Hock, E. Donal, 2023, The New England journal of medicine.

Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.

P. García-Pavía, M. Fiuzat, I. Lousada, 2024, Advances in therapy.